The role of the pathologist in the next-generation era of tumor molecular characterization V Angerilli, F Galuppini, F Pagni, N Fusco, U Malapelle, M Fassan Diagnostics 11 (2), 339, 2021 | 68 | 2021 |
The immunopathological and histological landscape of COVID-19-mediated lung injury G Zarrilli, V Angerilli, G Businello, M Sbaraglia, G Traverso, F Fortarezza, ... International Journal of Molecular Sciences 22 (2), 974, 2021 | 41 | 2021 |
FFPE-based NGS approaches into clinical practice: the limits of glory from a pathologist viewpoint F Cappello, V Angerilli, G Munari, C Ceccon, M Sabbadin, F Pagni, ... Journal of Personalized Medicine 12 (5), 750, 2022 | 36 | 2022 |
PD-L1 expression in gastroesophageal dysplastic lesions M Fassan, S Brignola, G Pennelli, G Alberti, V Angerilli, A Bressan, ... Virchows Archiv 477, 151-156, 2020 | 28 | 2020 |
PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application L Mastracci, F Grillo, P Parente, I Gullo, M Campora, V Angerilli, C Rossi, ... Pathologica 114 (5), 352, 2022 | 26 | 2022 |
The day-to-day practice of MMR and MSI assessment in colorectal adenocarcinoma: what we know and what we still need to explore P Parente, F Grillo, A Vanoli, MC Macciomei, MR Ambrosio, N Scibetta, ... Dig. Dis 41, 746-756, 2023 | 24 | 2023 |
Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study M Rizzato, S Brignola, G Munari, M Gatti, V Dadduzio, C Borga, ... European Journal of Cancer 166, 165-175, 2022 | 22 | 2022 |
Molecular landscapes of gastric pre-neoplastic and pre-invasive lesions G Businello, V Angerilli, P Parente, S Realdon, E Savarino, F Farinati, ... International Journal of Molecular Sciences 22 (18), 9950, 2021 | 22 | 2021 |
miRNAs involved in esophageal carcinogenesis and miRNA-related therapeutic perspectives in esophageal carcinoma G Zarrilli, F Galuppini, V Angerilli, G Munari, M Sabbadin, V Lazzarin, ... International journal of molecular sciences 22 (7), 3640, 2021 | 21 | 2021 |
Comprehensive genomic profiling (CGP)-informed personalized molecular residual disease (MRD) detection: an exploratory analysis from the PREDATOR study of metastatic colorectal … S Lonardi, H Nimeiri, C Xu, DR Zollinger, RW Madison, AD Fine, ... International Journal of Molecular Sciences 23 (19), 11529, 2022 | 17 | 2022 |
Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer G Randon, R Intini, C Cremolini, E Elez, MJ Overman, J Lee, P Manca, ... European Journal of Cancer 161, 90-98, 2022 | 16 | 2022 |
Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study G Arpa, M Fassan, C Guerini, E Quaquarini, F Grillo, V Angerilli, ... Virchows Archiv 481 (6), 853-863, 2022 | 15 | 2022 |
BRAF-mutated colorectal adenocarcinomas: Pathological heterogeneity and clinical implications V Angerilli, G Sabella, G Centonze, S Lonardi, F Bergamo, A Mangogna, ... Critical Reviews in Oncology/Hematology 172, 103647, 2022 | 15 | 2022 |
Multi-design differential expression profiling of COVID-19 lung autopsy specimens reveals significantly deregulated inflammatory pathways and SFTPC impaired transcription M Fassan, A Collesei, V Angerilli, M Sbaraglia, F Fortarezza, F Pezzuto, ... Cells 11 (6), 1011, 2022 | 14 | 2022 |
Evaluating mismatch repair deficiency in colorectal cancer biopsy specimens F Grillo, M Paudice, A Gambella, S Bozzano, S Sciallero, A Puccini, ... Histochemistry and Cell Biology 160 (2), 113-125, 2023 | 13 | 2023 |
HER2-low in gastro-oesophageal adenocarcinoma: a real-world pathological perspective V Angerilli, P Parente, M Campora, C Ugolini, S Battista, P Cassoni, ... Journal of Clinical Pathology 76 (12), 815-821, 2023 | 12 | 2023 |
A practical approach for PD-L1 evaluation in gastroesophageal cancer V Angerilli, M Fassan, P Parente, I Gullo, M Campora, C Rossi, ... Pathologica 115 (2), 57, 2022 | 12 | 2022 |
A real-world application of liquid biopsy in metastatic colorectal cancer: the Poseidon study L Procaccio, F Bergamo, F Daniel, C Rasola, G Munari, P Biason, ... Cancers 13 (20), 5128, 2021 | 11 | 2021 |
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer S Hedayat, L Cascione, D Cunningham, M Schirripa, A Lampis, JC Hahne, ... Clinical Cancer Research 30 (10), 2140-2159, 2024 | 9 | 2024 |
MicroRNAs as predictive biomarkers of resistance to targeted therapies in gastrointestinal tumors V Angerilli, F Galuppini, G Businello, L Dal Santo, E Savarino, S Realdon, ... Biomedicines 9 (3), 318, 2021 | 9 | 2021 |